Table 5 Effects of the ERAS program on postoperative complications of patients
Variable | ERAS (n = 60) | Control (n = 60) | p |
|---|---|---|---|
Readmission | 0 | 1 | 0.559 |
Redo VATS | 0 | 1 | 0.315 |
Minor complication | 5 (8.33%) | 14 (23.33%) | 0.024 |
pneumonia | 2 | 5 | 0.436 |
Air leak > 7 days | 1 | 3 | 0.611 |
Atelectasis | 0 | 2 | 0.476 |
Atrial fibrillation | 1 | 2 | 1.000 |
Urinary retention | 1 | 2 | 1.000 |
Major complication | 1 (1.6%) | 2 (3.3%) | 0.559 |
Chylothorax | 0 | 1 | 1.000 |
Pneumothorax | 1 | 1 | 1.000 |
Postoperative morbidity | 6 (10.0%) | 16 (26.7%) | 0.018 |